OKUR
OnKure Therapeutics, Inc.- Healthcare
- Biotechnology
- $102M market cap
Forecast run · Oct 29, 2026Upside rank 830 of 3,186
Model Signal
ForecastQ Daily Probabilities
37.8%
72.9%
35.1%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$2.52
Price target$14.00
Implied move+455.6%
Analysts2
ForecastQ Portfolios
OKUR is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.